CID 155753054

Paltimatrectinib

Structural Information

Molecular Formula
C20H15F5N6
SMILES
C1C[C@@H](N(C1)C2=NC3=C(C=NN3C=C2)N4C=C(C=N4)C(F)(F)F)C5=C(C=CC(=C5)F)F
InChI
InChI=1S/C20H15F5N6/c21-13-3-4-15(22)14(8-13)16-2-1-6-29(16)18-5-7-30-19(28-18)17(10-27-30)31-11-12(9-26-31)20(23,24)25/h3-5,7-11,16H,1-2,6H2/t16-/m1/s1
InChIKey
FYPXPQSPRRZJCK-MRXNPFEDSA-N
Compound name
5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]-3-[4-(trifluoromethyl)pyrazol-1-yl]pyrazolo[1,5-a]pyrimidine
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

78
Patents

434.12784 Da
Monoisotopic Mass

3.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 435.13512 195.9
[M+Na]+ 457.11706 208.1
[M-H]- 433.12056 198.6
[M+NH4]+ 452.16166 203.9
[M+K]+ 473.09100 199.3
[M+H-H2O]+ 417.12510 180.8
[M+HCOO]- 479.12604 206.5
[M+CH3COO]- 493.14169 203.8
[M+Na-2H]- 455.10251 190.8
[M]+ 434.12729 192.4
[M]- 434.12839 192.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe